A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy.

P D Kottaridis, R Chakraverty, D W Milligan, S Chakrabarti, S Robinson, R Chopra, R Pettengell, J Marsh, P Mahendra, S Schey, G H Morgan, C Williams, G Hale, H Waldmann, D C Linch, S Devereux, A H Goldstone, S Mackinnon

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)348A - 348A
JournalBlood
Volume94
Issue number10
Publication statusPublished - 1999

Cite this